Atlas Trials

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

Clinical trial NCT07372118 · COMPLETED

Trial details

NCT number
NCT07372118
Sponsor
Humanis Saglık Anonim Sirketi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2025-09-27
Primary completion
2025-12-29
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.